You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Integrase Strand Transfer Inhibitors

Showing 1 - 25 of 6,543
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gut Microbiota, PGx and INSTIs Response

Recruiting
  • HIV Infections
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Jan 16, 2023

Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

Not yet recruiting
  • Metabolic Effects
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

Recruiting
  • HIV I Infection
  • Adiposity
  • Frequently sampled glucose tolerance testing
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 15, 2022

HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

Recruiting
  • HIV Infections
  • Doravirine 100 Mg
  • +5 more
  • Birmingham, Alabama
  • +22 more
Feb 22, 2022

HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

Completed
Has Results
  • HIV
  • Switch to Maraviroc + Raltegravir or Dolutegravir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Oct 5, 2021

Assess the ART Impact on the Brain Outcomes. The ARBRE Study

Completed
Has Results
  • HIV-1 Infection
  • Cognitive Impairment
    • (no location specified)
    May 15, 2020

    Hiv, Weight Gain Trial in Toronto (DOR/3TC/TDF)

    Enrolling by invitation
    • Hiv
    • Weight Gain
    • Toronto, Ontario, Canada
      University Health Network
    May 17, 2022

    Bictegravir in the Elderly Living With HIV (BICEP)

    Active, not recruiting
    • HIV-1-infection
    • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
    • Buffalo, New York
      Evergreen Health
    Oct 28, 2022

    HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

    Recruiting
    • HIV/AIDS
    • Antwerp, Belgium
    • +47 more
    Jan 9, 2023

    HIV Trial in Paris (Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine)

    Not yet recruiting
    • HIV Infections
    • Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine
    • Paris, Ile De France, France
      Christine Katlama
    Jul 26, 2022

    HIV-1 Infection Trial in France (Samplings)

    Recruiting
    • HIV-1 Infection
    • Samplings
    • Clamart, France
    • +6 more
    Jan 4, 2022

    Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

    Not yet recruiting
    • Multi Drug Resistant Tuberculosis
    • HIV Infections
    • Adherence support intevention
    • Durban, KwaZulu-Natal, South Africa
      King DinuZulu Hospital
    Nov 21, 2022

    HIV, Clinical Outcomes, Adverse Drug Event Trial in Salvador, São Paulo (No intervention)

    Recruiting
    • HIV Infections
    • +3 more
    • No intervention
    • Salvador, Bahia, Brazil
    • +2 more
    Mar 15, 2022

    HIV-1-infection Trial in London (Doravirine, Dolutegravir, Triple cART regimen)

    Not yet recruiting
    • HIV-1-infection
    • London, United Kingdom
      Chelsea & Westminster Hospital NHS Foundation Trust
    Jun 23, 2021

    NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

    Not yet recruiting
    • Nonalcoholic Fatty Liver Disease
    • +3 more
      • (no location specified)
      Apr 18, 2022

      Contributing Factors for Poor HIV Treatment Response in TB/HIV

      Recruiting
      • Tuberculosis
      • +2 more
      • Observational study
      • Kumasi, Ghana
        Kwame Nkrumah University of Science and Technology
      Mar 23, 2022

      HIV Trial in Rio De Janeiro (Cabotegravir Injection)

      Not yet recruiting
      • HIV Infections
      • Cabotegravir Injection
      • Rio De Janeiro, Brazil
        Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
      Aug 23, 2022

      HIV-1-infection, Antiretroviral Therapy Trial in Port-au-Prince (Continuation of boosted PI, B/F/TAF)

      Not yet recruiting
      • HIV-1-infection
      • Antiretroviral Therapy
      • Port-au-Prince, Haiti
        GHESKIO
      Jul 30, 2020

      Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

      Completed
      • Medication Adherence
      • HIV
      • dolutegravir oral tablet 50mg
      • +3 more
      • Pittsburgh, Pennsylvania
        HIV/AIDS Clinical Research Unit / University of Pittsburgh
      Mar 2, 2022

      Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)

      Recruiting
      • Breast Feeding
      • +3 more
      • Venipuncture
      • Leuven, Vlaams-Brabant, Belgium
        Universitaire Ziekenhuizen Leuven
      Oct 12, 2023

      HIV-1 Infection Trial in United States (Bictegravir, Placebo)

      Completed
      Has Results
      • HIV-1 Infection
      • Berkeley, California
      • +15 more
      Oct 16, 2020

      Relapse, Orthodontic Retention Trial in Athens (Experimental: Single strand ß-Ti fixed retainer, Experimental: SS fixed

      Recruiting
      • Relapse
      • Orthodontic Retention
      • Experimental: Single strand β-Ti fixed retainer
      • +2 more
      • Athens, Attiki, Greece
        National and Kapodistrian University of Athens, School of Dentis
      Jun 29, 2023

      Homologous Recombination Deficiency, Triple Negative Breast Cancer Trial (Niraparib)

      Not yet recruiting
      • Homologous Recombination Deficiency
      • Triple Negative Breast Cancer
      • (no location specified)
      Jul 15, 2022

      HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

      Recruiting
      • HIV I Infection
      • +2 more
      • Doravirine 100 Mg
      • Los Angeles, California
      • +1 more
      Nov 1, 2022

      HIV, Drug, Resistance Trial (Tenofovir Disoproxil)

      Unknown status
      • HIV
      • +2 more
      • Tenofovir Disoproxil
      • (no location specified)
      Jul 22, 2020